Transcribed

Personal journeys and hard-earned lessons behind biotech’s biggest breakthroughs

Featured interview

with Nicole Paulk

CEO and Founder
Siren Biotechnology

What if one gene therapy could treat 200 diseases? Siren CEO Nicole Paulk on turning COVID lockdown frustration into a $6M startup, chasing unpopular ideas, and why biotech has to move faster and cheaper to survive.

View now

Podcast available on

More stories

Watch

Gleb Kuznetsov on breaking the in vivo bottleneck and building a true platform company

Read

Eric Kelsic on breaking with convention and how Dyno Therapeutics is solving the gene delivery prob…

Listen

Andrew Bellinger on contrarian bets — and pioneering gene editing at Verve

Watch

Jake Becraft on going all in on mRNA and proving skeptics wrong

Watch

Karen Akinsanya on the future of computational drug discovery and Schrödinger’s model for success

Read

John Tsai on the power of clinical development and the road to blockbuster drugs

Transcribed